Gastro Hep AdvancesGenetic & Genomic MedicinePeer-reviewed journal article
LMNA R644C associates with hepatic steatosis in a large cohort and increases cellular lipid droplet accumulation in vitro
Kapil K. UpadhyayiD, Yanhua CheniD, Xiaomeng Du, Lishi Yin, Chinmay RautiD, Elizabeth K. SpeliotesiD, Graham F. BradyiD
Abstract
The R644C variant of lamin A is controversial, as it has been linked to multiple phenotypes in familial studies, but has also been identified in apparently healthy volunteers. Here we present data from a large midwestern US cohort showing that this variant associates genetically with hepatic steatosis, and with related traits in additional publicly available datasets, while in vitro testing demonstrated that this variant increased cellular lipid droplet accumulation. Taken together, these data support this LMNA variants potential pathogenicity in lipodystrophy and metabolic liver disease.
- organism: human
- research focus: genome assembly
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 1th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reduced ZMPSTE24 expression leads to prelamin accumulation and development of steatosis in MASLD patients.
Joseph D. Schinderle, Anqi Wu, Irina M. Bochkis·Scientific ReportsPeer-reviewed·Nov 26, 2025
- Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis and steatohepatitis in male mice
K. K. Upadhyay, E.-Y. K. Choi, … G. F. Brady·bioRxiv·Mar 18, 2022
- Machine learning enables new insights into clinical significance of and genetic contributions to liver fat accumulation
Mary E. Haas, James P. Pirruccello, … Amit V. Khera·Cell GenomicsPeer-reviewed·Dec 1, 2021
- RAB18 confers protection to lipid droplets from lysolipophagy and counters cellular steatosis
A. Rieck, G. Guenther, … N. Vartak·bioRxiv·Mar 11, 2023
- Prime Editing Models the MTARC1 A165T Variant in Human Liver Organoids, Demonstrating Reduced Steatosis, Inflammation, and Fibrosis
Amel Ben Saad, Nahid Arghiani, … Alan C. Mullen·Hepatology CommunicationsPeer-reviewed·Sep 16, 2026
- Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis
Ikki Sakuma, Rafael Calais Gaspar, … Gerald I. Shulman·Proceedings of the National Academy of SciencesPeer-reviewed·May 1, 2025